首页> 外文期刊>The Biochemical Journal >Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.
【24h】

Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.

机译:胰高血糖素受体的突变分析:与血管活性肠肽(VIP)/垂体腺苷酸环化酶激活肽(PACAP)/分泌素受体的相似性,用于识别配体的第三个残基。

获取原文
获取原文并翻译 | 示例
           

摘要

Receptor recognition by the Asp(3) residues of vasoactive intestinal peptide and secretin requires the presence of a lysine residue close to the second transmembrane helix (TM2)/first extracellular loop junction and an ionic bond with an arginine residue in TM2. We tested whether the glucagon Gln(3) residue recognizes the equivalent positions in its receptor. Our data revealed that the binding and functional properties of the wild-type glucagon receptor and the K188R mutant were not significantly different, whereas all agonists had markedly lower potencies and affinities at the I195K mutated receptor. In contrast, glucagon was less potent and the Asp(3)-, Asn(3)- and Glu(3)-glucagon mutants were more potent and efficient at the double-mutated K188R/I195K receptor. Furthermore, these alterations were selective for position 3 of glucagon, as shown by the functional properties of the mutant Glu(9)- and Lys(15)-glucagon. Our results suggest that although the Gln(3) residue of glucagon did not interact withthe equivalent binding pocket as the Asp(3) residue of vasoactive intestinal peptide or secretin, the Asp(3)-glucagon analogue was able to interact with position 188 of the K188R/I195K glucagon receptor. Nevertheless, the Gln(3) side chain of glucagon probably binds very close to this region in the wild-type receptor.
机译:血管活性肠肽和促胰液素的Asp(3)残基识别受体需要在第二个跨膜螺旋(TM2)/第一个细胞外环结附近存在一个赖氨酸残基,并在TM2中存在一个带有精氨酸残基的离子键。我们测试了胰高血糖素Gln(3)残基是否识别其受体中的等效位置。我们的数据表明,野生型胰高血糖素受体和K188R突变体的结合和功能特性没有显着差异,而所有激动剂对I195K突变受体的效价和亲和力均明显较低。相比之下,胰高血糖素的效力较低,而Asp(3)-,Asn(3)-和Glu(3)-胰高血糖素突变体在双突变K188R / I195K受体上的效力和效率更高。此外,如突变体Glu(9)-和Lys(15)-胰高血糖素的功能特性所示,这些改变对胰高血糖素的3位具有选择性。我们的结果表明,尽管胰高血糖素的Gln(3)残基不与​​血管活性肠肽或促胰液素的Asp(3)残基同等的结合袋相互作用,但Asp(3)-胰高血糖素类似物能够与188位的胰高血糖素相互作用。 K188R / I195K胰高血糖素受体。但是,胰高血糖素的Gln(3)侧链可能与野生型受体中的该区域非常接近地结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号